143 related articles for article (PubMed ID: 33655828)
1. Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure.
Tariq U; Uppulapu SK; Banerjee SK
Curr Drug Targets; 2021; 22(13):1568-1576. PubMed ID: 33655828
[TBL] [Abstract][Full Text] [Related]
2. Cardiac fibroblast GSK-3α aggravates ischemic cardiac injury by promoting fibrosis, inflammation, and impairing angiogenesis.
Umbarkar P; Ejantkar S; Ruiz Ramirez SY; Toro Cora A; Zhang Q; Tousif S; Lal H
Basic Res Cardiol; 2023 Sep; 118(1):35. PubMed ID: 37656238
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.
Lal H; Zhou J; Ahmad F; Zaka R; Vagnozzi RJ; Decaul M; Woodgett J; Gao E; Force T
Circulation; 2012 Jan; 125(1):65-75. PubMed ID: 22086876
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.
Ahmad F; Singh AP; Tomar D; Rahmani M; Zhang Q; Woodgett JR; Tilley DG; Lal H; Force T
J Mol Cell Cardiol; 2019 May; 130():65-75. PubMed ID: 30928428
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.
Woulfe KC; Gao E; Lal H; Harris D; Fan Q; Vagnozzi R; DeCaul M; Shang X; Patel S; Woodgett JR; Force T; Zhou J
Circ Res; 2010 May; 106(10):1635-45. PubMed ID: 20360256
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload.
Matsuda T; Zhai P; Maejima Y; Hong C; Gao S; Tian B; Goto K; Takagi H; Tamamori-Adachi M; Kitajima S; Sadoshima J
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20900-5. PubMed ID: 19106302
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.
Umbarkar P; Tousif S; Singh AP; Anderson JC; Zhang Q; Tallquist MD; Woodgett J; Lal H
Circ Res; 2022 Sep; 131(7):620-636. PubMed ID: 36052698
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
[TBL] [Abstract][Full Text] [Related]
10. Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.
Lal H; Ahmad F; Zhou J; Yu JE; Vagnozzi RJ; Guo Y; Yu D; Tsai EJ; Woodgett J; Gao E; Force T
Circulation; 2014 Jul; 130(5):419-30. PubMed ID: 24899689
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
12. GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice.
Zhou J; Lal H; Chen X; Shang X; Song J; Li Y; Kerkela R; Doble BW; MacAulay K; DeCaul M; Koch WJ; Farber J; Woodgett J; Gao E; Force T
J Clin Invest; 2010 Jul; 120(7):2280-91. PubMed ID: 20516643
[TBL] [Abstract][Full Text] [Related]
13. GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit.
Umbarkar P; Ruiz Ramirez SY; Toro Cora A; Tousif S; Lal H
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166724. PubMed ID: 37094727
[TBL] [Abstract][Full Text] [Related]
14. The GSK-3 family as therapeutic target for myocardial diseases.
Lal H; Ahmad F; Woodgett J; Force T
Circ Res; 2015 Jan; 116(1):138-49. PubMed ID: 25552693
[TBL] [Abstract][Full Text] [Related]
15. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation.
Kerkela R; Kockeritz L; Macaulay K; Zhou J; Doble BW; Beahm C; Greytak S; Woulfe K; Trivedi CM; Woodgett JR; Epstein JA; Force T; Huggins GS
J Clin Invest; 2008 Nov; 118(11):3609-18. PubMed ID: 18830417
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte-GSK-3β deficiency induces cardiac progenitor cell proliferation in the ischemic heart through paracrine mechanisms.
Yusuf AM; Qaisar R; Al-Tamimi AO; Jayakumar MN; Woodgett JR; Koch WJ; Ahmad F
J Cell Physiol; 2022 Mar; 237(3):1804-1817. PubMed ID: 34812500
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
18. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells.
Cho J; Rameshwar P; Sadoshima J
J Biol Chem; 2009 Dec; 284(52):36647-36658. PubMed ID: 19858210
[TBL] [Abstract][Full Text] [Related]
20. Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival.
Liang MH; Chuang DM
J Biol Chem; 2007 Feb; 282(6):3904-17. PubMed ID: 17148450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
